Concepedia

Publication | Open Access

Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib

53

Citations

34

References

2013

Year

Abstract

Dovitinib showed modest antitumour activity with manageable toxicities in heavily pretreated patients with advanced GISTs.

References

YearCitations

Page 1